Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>DNA damage>DNA / RNA Synthesis antagonists>Flupirtine Maleate
Flupirtine Maleate
  • Flupirtine Maleate
  • Flupirtine Maleate
  • Flupirtine Maleate
  • Flupirtine Maleate
  • Flupirtine Maleate

Flupirtine Maleate NEW

Price Get Latest Price
Package 1kg
Min. Order: 1kg
Supply Ability: 10000kg
Update Time: 2024-04-29

Product Details

Product Name: Flupirtine Maleate CAS No.: 75507-68-5
EC-No.: 278-225-0 Min. Order: 1kg
Purity: 99% Supply Ability: 10000kg
Release date: 2024/04/29

Factory Provide Analgesic CAS 75507-68-5 Flupirtine Raw Material Flupirtine Maleate Powder


Article illustration

Introduction

Product Name :Flupirtine Maleate

Othe name :2-AMINO-6-[[(4-FLUOROPHENYL)METHYL]AMINO]-3-PYRIDINYL]-CARBAMIC ACID, ETHYL ESTER MALEATE;Flupirtinemaleatelupirtine

CAS No. 75507-68-5

EINECS No. 278-225-0

Molecular Formula: C19H21FN4O6

MW:420.3916432

Assay: 99%
Appearance: White powder
Melting Point :186-188°C

Storage :Keep in a cool, dry, dark location


  Flupirtine maleate is a selective neurogenic potassium channel opener. It is easily absorbed by oral administration. It has three functions of pain relief, muscle relaxation and neuroprotection. It has analgesic effect on pain caused by various reasons. It has no affinity with opioid receptors, nor does it inhibit the synthesis of Chemicalbook prostaglandins. It is not antagonized by naloxone. Its analgesic strength (ED50) is weaker than that of methadona, buprenorphine and morphina, which is about 50% of that of morphina. Zocine is equivalent, stronger than pethidina, codeina, phenaceti and acetaminophen.

Application
Flupirtine maleate has an inhibitory effect on pain caused by various diseases, and its analgesic effect is between methadona and paracetamol. It acts on the center, but does not inhibit the respiratory and cardiovascular systems and affect the pharmacological activity of the cough center, nor does it produce constipation and urinary retention. Long-term use does not produce tolerance and dependence. No side effects of painkillers on the market, such as addiction, digestive tract symptoms, etc. After long-term use for several years, the curative effect will not be reduced, but the dosage can be reduced. In short, flupirtine maleate has good clinical application prospects.

Article illustration




Company Profile Introduction

Shaanxi TNJONE Pharmaceutical Co., Ltd supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Shaanxi TNJONE Pharmaceutical Co., Ltd.'s marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1G
VIP1Y
CONTIDE BIOTECH CO.,LTD
2024-04-12
$20.00/1kg
VIP1Y
Shaanxi Franta Biotechnology Co., Ltd
2024-04-02
$600.00/100g
VIP4Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-08
$30.00/1kg
Anhui Ruihan Technology Co., Ltd
2023-09-08
$66.00/1KG
Xiamen Wonderful Bio Technology Co., Ltd.
2023-07-21
$50.00/1kg
VIP2Y
Hebei Miaoyin Technology Co.,Ltd
2023-03-09
$10.00/1kg
Hebei Linwo New Material Technology Co., LTD
2022-06-23
$0.00/25ASSAYS
VIP4Y
Hebei Mojin Biotechnology Co., Ltd
2021-10-14
$10.00/1KG
VIP3Y
Wuhan wingroup Pharmaceutical Co., Ltd
2021-08-03
$10.00/1Kg/Drum
VIP3Y
Hebei Guanlang Biotechnology Co,.LTD
2021-07-12

Shaanxi TNJONE Pharmaceutical Co., Ltd

1YR ChinaChina
  • Since: 2019-05-23
  • Address: No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New C
INQUIRY